semaglutide approval date GoodRx announced that it will begin selling both of Novo Nordisk's GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at a cash price of $499 per month. The partnership comes FDA Warns on Certain Forms

doi: 10.3389/FENDO.2022.851035

doi: 10.1002/cbic.201800346

37 Thus, outcomes relevant for seeking accelerated approval during future phase III RCTs with a longer duration of follow-up are ongoing

You start at a lower dose and increase it over several weeks

Key takeaways GLP-1s are effective at lowering weight, hemoglobin A1C levels, and cardiovascular risk, but their effects are only sustained if taken continuously

09/27/24 Dupixent (dupilumab) for COPD New indication approval September 27, 2024 - Regeneron and Sanofi announced the approval of a new indication for Dupixent (dupilumab) for chronic obstructive pulmonary disease COPD)